Anti-infective drug development company with its German operating company in Berlin and origins in a Singapore natural products research institute spun out in 2002. Develops finafloxacin, a fluoroquinolone antibiotic designed to work in the acidic conditions of infected tissue, marketed as an ear drop for otitis externa and taken into trials for complicated urinary tract infection and other indications, and works on further anti-infective candidates drawn from natural product and synthetic chemistry.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen